Selected research
Industry Research
Lomustine Industry Research Report 2026
Market perspective
The global Lomustine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Lomustine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Lomustine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Lomustine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Lomustine include Zhongfu Pharma, Nanjing Pharma, Bristol-Myers Squibb, Ther Dose, NextSource Pharma, Miracalus Pharma, Medicon Pharma and ACTIZA, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Lomustine market in terms of revenue (US$ million) and, where applicable, service volume (kg), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Lomustine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lomustine Market by Company
Zhongfu Pharma
Nanjing Pharma
Bristol-Myers Squibb
Ther Dose
NextSource Pharma
Miracalus Pharma
Medicon Pharma
ACTIZA
Lomustine Segment by Type
10mg/Tablet
40mg/Tablet
100mg/Tablet
Lomustine Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Lomustine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lomustine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lomustine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lomustine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Lomustine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/Tablet
- 40mg/Tablet
- 100mg/Tablet
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Zhongfu Pharma
- Nanjing Pharma
- Bristol-Myers Squibb
- Ther Dose
- NextSource Pharma
- Miracalus Pharma
- Medicon Pharma
- ACTIZA
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Lomustine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 10mg/Tablet
- 2.2.3 40mg/Tablet
- 2.2.4 100mg/Tablet
- 2.3 Lomustine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Retail Pharmacies
- 2.4 Assumptions and Limitations
3 Lomustine Breakdown Data by Type
- 3.1 Global Lomustine Historic Market Size by Type (2021-2026)
- 3.2 Global Lomustine Forecasted Market Size by Type (2027-2032)
4 Lomustine Breakdown Data by Application
- 4.1 Global Lomustine Historic Market Size by Application (2021-2026)
- 4.2 Global Lomustine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Lomustine Market Perspective (2021-2032)
- 5.2 Global Lomustine Growth Trends by Region
- 5.2.1 Global Lomustine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Lomustine Historic Market Size by Region (2021-2026)
- 5.2.3 Lomustine Forecasted Market Size by Region (2027-2032)
- 5.3 Lomustine Market Dynamics
- 5.3.1 Lomustine Industry Trends
- 5.3.2 Lomustine Market Drivers
- 5.3.3 Lomustine Market Challenges
- 5.3.4 Lomustine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Lomustine Players by Revenue
- 6.1.1 Global Top Lomustine Players by Revenue (2021-2026)
- 6.1.2 Global Lomustine Revenue Market Share by Players (2021-2026)
- 6.2 Global Lomustine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Lomustine Head Office and Area Served
- 6.4 Global Lomustine Players, Product Type & Application
- 6.5 Global Lomustine Manufacturers Established Date
- 6.6 Global Lomustine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Lomustine Market Size (2021-2032)
- 7.2 North America Lomustine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Lomustine Market Size by Country (2021-2026)
- 7.4 North America Lomustine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Lomustine Market Size (2021-2032)
- 8.2 Europe Lomustine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Lomustine Market Size by Country (2021-2026)
- 8.4 Europe Lomustine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Lomustine Market Size (2021-2032)
- 9.2 Asia-Pacific Lomustine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Lomustine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Lomustine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Lomustine Market Size (2021-2032)
- 10.2 South America Lomustine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Lomustine Market Size by Country (2021-2026)
- 10.4 South America Lomustine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Lomustine Market Size (2021-2032)
- 11.2 Middle East & Africa Lomustine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Lomustine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Lomustine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zhongfu Pharma
- 12.1.1 Zhongfu Pharma Company Information
- 12.1.2 Zhongfu Pharma Business Overview
- 12.1.3 Zhongfu Pharma Revenue in Lomustine Business (2021-2026)
- 12.1.4 Zhongfu Pharma Lomustine Product Portfolio
- 12.1.5 Zhongfu Pharma Recent Developments
- 12.2 Nanjing Pharma
- 12.2.1 Nanjing Pharma Company Information
- 12.2.2 Nanjing Pharma Business Overview
- 12.2.3 Nanjing Pharma Revenue in Lomustine Business (2021-2026)
- 12.2.4 Nanjing Pharma Lomustine Product Portfolio
- 12.2.5 Nanjing Pharma Recent Developments
- 12.3 Bristol-Myers Squibb
- 12.3.1 Bristol-Myers Squibb Company Information
- 12.3.2 Bristol-Myers Squibb Business Overview
- 12.3.3 Bristol-Myers Squibb Revenue in Lomustine Business (2021-2026)
- 12.3.4 Bristol-Myers Squibb Lomustine Product Portfolio
- 12.3.5 Bristol-Myers Squibb Recent Developments
- 12.4 Ther Dose
- 12.4.1 Ther Dose Company Information
- 12.4.2 Ther Dose Business Overview
- 12.4.3 Ther Dose Revenue in Lomustine Business (2021-2026)
- 12.4.4 Ther Dose Lomustine Product Portfolio
- 12.4.5 Ther Dose Recent Developments
- 12.5 NextSource Pharma
- 12.5.1 NextSource Pharma Company Information
- 12.5.2 NextSource Pharma Business Overview
- 12.5.3 NextSource Pharma Revenue in Lomustine Business (2021-2026)
- 12.5.4 NextSource Pharma Lomustine Product Portfolio
- 12.5.5 NextSource Pharma Recent Developments
- 12.6 Miracalus Pharma
- 12.6.1 Miracalus Pharma Company Information
- 12.6.2 Miracalus Pharma Business Overview
- 12.6.3 Miracalus Pharma Revenue in Lomustine Business (2021-2026)
- 12.6.4 Miracalus Pharma Lomustine Product Portfolio
- 12.6.5 Miracalus Pharma Recent Developments
- 12.7 Medicon Pharma
- 12.7.1 Medicon Pharma Company Information
- 12.7.2 Medicon Pharma Business Overview
- 12.7.3 Medicon Pharma Revenue in Lomustine Business (2021-2026)
- 12.7.4 Medicon Pharma Lomustine Product Portfolio
- 12.7.5 Medicon Pharma Recent Developments
- 12.8 ACTIZA
- 12.8.1 ACTIZA Company Information
- 12.8.2 ACTIZA Business Overview
- 12.8.3 ACTIZA Revenue in Lomustine Business (2021-2026)
- 12.8.4 ACTIZA Lomustine Product Portfolio
- 12.8.5 ACTIZA Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst